Bill Text: IL SR0872 | 2021-2022 | 102nd General Assembly | Introduced

---

Bill Title: Declares the week of May 1, 2022 as Tardive Dyskinesia Awareness Week. Encourages the citizens of Illinois to become better informed about Tardive Dyskinesia.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2022-05-10 - Pursuant to Senate Rule 3-9(b) / Referred to Assignments [SR0872 Detail]

Download: Illinois-2021-SR0872-Introduced.html

---

SR0872 LRB102 26365 MST 36528 r
SENATE RESOLUTION
WHEREAS, Many peoples with serious, chronic mental
illness, such as schizophrenia and other schizoaffective
disorders, bipolar disorder, or severe depression, require
treatment with medications that work as dopamine receptor
blocking agents (DRBAs), including antipsychotics; and
WHEREAS, While ongoing treatment with these medications
can be very helpful and even lifesaving, for many people, it
can also lead to Tardive Dyskinesia (TD); and
WHEREAS, Many people who have gastrointestinal disorders,
including gastroparesis, nausea, and vomiting, also require
treatment with DRBAs; and
WHEREAS, Treatment of gastrointestinal disorders with
DRBAs can be very helpful, but for many patients, it can lead
to Tardive Dyskinesia; and
WHEREAS, Tardive Dyskinesia is a movement disorder that is
characterized by random, involuntary, and uncontrolled
movements of different muscles in the face, trunk, and
extremities; in some cases, people may experience movement of
the arms, legs, fingers, and toes; it may affect the tongue,
lips, and jaw; symptoms may include swaying movements of the

SR0872 - 2 - LRB102 26365 MST 36528 r
trunk or hips and may impact the muscles associated with
walking, speech, eating, and breathing; and
WHEREAS, Tardive Dyskinesia can develop months, years, or
decades after a person starts taking DRBAs and even after they
have discontinued use of those medications; not everyone who
takes a DRBA develops TD, but if it develops, it is often
permanent; and
WHEREAS, Common risk factors for Tardive Dyskinesia
include advanced age and alcoholism or other substance abuse
disorders; postmenopausal women and people with a mood
disorder are also at higher risk of developing Tardive
Dyskinesia; and
WHEREAS, A person is at higher risk for TD after taking
DRBAs for three months or longer, but the longer the person is
on these medications then the higher the risk of developing
Tardive Dyskinesia; and
WHEREAS, Studies suggest that overall risk of developing
Tardive Dyskinesia is between 10 and 30 percent; and
WHEREAS, It is estimated that over 600,000 Americans
suffer from Tardive Dyskinesia; according to the National
Alliance for Mental Illness, one in every four patients

SR0872 - 3 - LRB102 26365 MST 36528 r
receiving long-term treatment with an antipsychotic medication
will experience Tardive Dyskinesia; and
WHEREAS, Years of difficult and challenging research have
resulted in recent scientific breakthroughs, with two new
treatments for Tardive Dyskinesia approved by the United
States Food and Drug Administration; and
WHEREAS, Tardive Dyskinesia is often unrecognized, and
patients suffering from the illness are commonly misdiagnosed;
regular screening for TD in patients taking DRBA medications
is recommended by the American Psychiatric Association (APA);
and
WHEREAS, Patients suffering from Tardive Dyskinesia often
suffer embarrassment due to abnormal and involuntary
movements, which leads them to withdraw from society and
increasingly isolate themselves as the disease progresses; and
WHEREAS, Caregivers of patients with Tardive Dyskinesia
face many challenges and are often responsible for the overall
care of the TD patient; and
WHEREAS, The Legislature can raise awareness of Tardive
Dyskinesia in the public and in the medical community;
therefore, be it

SR0872 - 4 - LRB102 26365 MST 36528 r
RESOLVED, BY THE SENATE OF THE ONE HUNDRED SECOND GENERAL
ASSEMBLY OF THE STATE OF ILLINOIS, that we declare the week of
May 1, 2022 as "Tardive Dyskinesia Awareness Week" in the
State of Illinois; and be it further
RESOLVED, That we encourage the citizens of Illinois to
become better informed about Tardive Dyskinesia.